References
- Dickens FB, Weglicki WB, Boehme PA, Mak TI. (2002). Antioxidant and lysosomotropic properties of acridine-propranolol: protection against oxidative endothelial cell injury. J Mol Cell Cardiol 34:129–37
- El-Saharty SY. (2003). Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study. J Pharm Biomed Anal 33:699–709
- Ellman LG. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
- Espinosa Bosch M, Ruiz Sánchez AJ, Sánchez Rojas F, Bosch Ojeda C. (2008). Recent developments in analytical determination of furosemide. J Pharm Biomed Anal 48:519–32
- Fecondo VJ and Augusteyn RC. (1983). Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp Eye Res 36:15–23
- Gammella E, Leuenberger C, Gassmann M, Ostergaard L. (2013). Evidence of synergistic/additive effects of sildenafil and erythropoietin in enhancing survival and migration of hypoxic endothelial cells. Am J Physiol – Lung Cell Mol Physiol 304:L230–9
- Glantzounis KG, Salacinski HJ, Yang W, et al. (2005). The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transplant 11:1031–47
- Guan S, Tee W, Ng D, et al. (2013). Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol 168:1707–18
- Hayes DJ, McLellan LI. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radical Res 31:273–300
- Jin Y, Pan X, Fu Z. (2012). Exposure to bifenthrin causes immunotoxicity and oxidative stress in male mice. Environ Toxico. [Epub ahead of print]. DOI: 10.1002/tox.21829
- Kastelova A, Dimova S, Nemery B. (2003). Propranolol cytotoxicity in rat and human lung in vitro. Methods Find Exp Clin Pharmacol 25:509–15
- Lahet JJ, Lenfant F, Courderot-Masuyer C, et al. (2003). In vivo and in vitro antioxidant properties of furosemide. Life Sci 73:1075–82
- Maiani G, Mobarhan S, Nicastro A, et al. (1983). Determination of glutathione reductase activity in erythrocytes and whole blood as an indicator of riboflavin nutrition. Acta Vitaminol Enzymol 5:171–8
- Mak TI, Chmielinska JJ, Nedelec L, et al. (2006). D-propranolol attenuates lysosomal iron accumulation and oxidative injury in endothelial cells. J Pharmacol Exp Ther 317:522–8
- Mak TI, Weglicki WB. (1988). Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circulation Res 63:262–6
- Mak TI, Weglicki WB. (2004). Potent antioxidant properties of 4-hydroxyl-propranolol. J Pharmacol Exp Ther 308:85–90
- Masella RR, Di Benedetto R, Varì R, et al. (2005). Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16:577–86
- Meister A, Anderson ME. (1983). Glutathione. Annu Rev Biochem 52:711–60
- Mosmanne T. (1983). Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–65
- Mostafavi-Pour Z, Zal F, Monabati A, Vessal M. (2008). Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatol Res 38:385–92
- Nies AS. (1990). Propranolol. Part II: non-cardioselective beta-adrenoreceptor blockers. In Messerli FH, ed. Cardiovascular drug therapy. Philadelphia: Saunders Company, 420–41
- Powers KS, Lennon SL. (1999). Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proceedings-Nutrition Society of London, Cambridge Univ Press
- Qin Y, Li L, Chen J, et al. (2012). Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitro. Oncol Res 20:61–9
- Rajamanikandan S, Sindhu T, Durgapriya D, et al. (2012). Protective effect of Mollugo nudicaulis Lam. on acute liver injury induced by perchloroethylene in experimental rats. Asian Pacific J Tropical Med 5:862–7
- Rezzani R. (2006). Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol 21:301–16
- Weglicki W, Mak I, Simìc M. (1990). Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 22:1199–208
- Williams DP, Antoine DJ, Butler PJ, et al. (2007). The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322:1208–20